Unicycive Therapeutics Correlations

UNCY Stock

USD 0.69 0.01 1.47%

The current 90-days correlation between Unicycive Therapeutics and Transcode Therapeutics is 0.01 (i.e., Significant diversification). The correlation of Unicycive Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Unicycive Therapeutics Correlation With Market

Modest diversification

The correlation between Unicycive Therapeutics and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unicycive Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Unicycive Stock please use our How to Invest in Unicycive Therapeutics guide.

Moving together with Unicycive Stock

0.7	VTRS	Viatris	Pair Corr
0.76	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.62	EWTX	Edgewise Therapeutics	Pair Corr
0.73	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.81	GILD	Gilead Sciences	Pair Corr
0.76	MNMD	Mind Medicine	Pair Corr
0.77	CPRX	Catalyst Pharmaceuticals	Pair Corr

Moving against Unicycive Stock

0.79	RDY	Dr Reddys Laboratories	Pair Corr
0.76	TAK	Takeda Pharmaceutical	Pair Corr
0.74	LLY	Eli Lilly	Pair Corr
0.71	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.66	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.65	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.65	ZTS	Zoetis Inc	Pair Corr
0.61	HLN	Haleon plc	Pair Corr
0.58	ELAN	Elanco Animal Health	Pair Corr
0.73	ANRO	Alto Neuroscience,	Pair Corr
0.62	AMGN	Amgen Inc	Pair Corr
0.56	LTRN	Lantern Pharma	Pair Corr
0.51	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.47	REVB	Revelation Biosciences	Pair Corr
0.47	TEVA	Teva Pharma Industries	Pair Corr
0.36	DRMAW	Dermata Therapeutics	Pair Corr
0.31	ABBV	AbbVie Inc Sell-off Trend	Pair Corr

Related Correlations Analysis

	RNAZ	AMAM	CDIO	HILS	SQL
RNAZ		0.52	-0.6	-0.52	0.12	RNAZ
AMAM	0.52		-0.08	-0.64	-0.08	AMAM
CDIO	-0.6	-0.08		0.48	-0.23	CDIO
HILS	-0.52	-0.64	0.48		0.03	HILS
SQL	0.12	-0.08	-0.23	0.03		SQL
	RNAZ	AMAM	CDIO	HILS	SQL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AMAM	+ 0.52	RNAZ
HILS	+ 0.48	CDIO
SQL	+ 0.12	RNAZ
SQL	+ 0.03	HILS

High negative correlations

HILS	- 0.64	AMAM
CDIO	- 0.6	RNAZ
HILS	- 0.52	RNAZ
SQL	- 0.23	CDIO
SQL	- 0.08	AMAM
CDIO	- 0.08	AMAM

Risk-Adjusted Indicators

There is a big difference between Unicycive Stock performing well and Unicycive Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Unicycive Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RNAZ	8.17	1.11	0.10	(0.56)	6.97	(12.15)	22.00	(11.43)	68.80
AMAM	3.64	0.41	0.09	0.42	4.78	(3.72)	6.05	(7.28)	29.96
CDIO	6.33	(0.58)	(0.01)	0.01	6.76	(10.01)	14.81	(13.16)	57.04
HILS	5.56	(0.90)	0.00	(0.22)	0.00	0.00	8.33	(7.89)	113.15
SQL	4.56	0.32	(0.01)	(0.06)	4.49	(8.97)	12.50	(10.64)	50.87

Unicycive Therapeutics Corporate Management

MPA MD	Chairman, Founder	Profile
Pramod Gupta	Executive Operations	Profile
John CPA	Chief Officer	Profile
Douglas MBA	Executive Strategy	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC